T-cell trafficking in the central nervous system

Immunol Rev. 2012 Jul;248(1):216-27. doi: 10.1111/j.1600-065X.2012.01140.x.

Abstract

To perform their distinct effector functions, pathogen-specific T cells have to migrate to target tissue where they recognize antigens and produce cytokines that elicit appropriate types of protective responses. Similarly, migration of pathogenic self-reactive T cells to target organs is an essential step required for tissue-specific autoimmunity. In this article, we review data from our laboratory as well as other laboratories that have established that effector function and migratory capacity are coordinately regulated in different T-cell subsets. We then describe how pathogenic T cells can enter into intact or inflamed central nervous system (CNS) to cause experimental autoimmune encephalomyelitis or multiple sclerosis. In particular, we elaborate on the role of CCR6/CCL20 axis in migration through the choroid plexus and the involvement of this pathway in immune surveillance of and autoimmunity in the CNS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmunity
  • Blood-Brain Barrier / immunology
  • Blood-Brain Barrier / pathology
  • Cell Movement / immunology*
  • Central Nervous System / immunology*
  • Central Nervous System / pathology
  • Choroid Plexus / immunology
  • Choroid Plexus / pathology
  • Humans
  • Immunologic Surveillance
  • Inflammation / immunology
  • Inflammation / pathology
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / pathology
  • Multiple Sclerosis / therapy
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism